{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T07:04:28Z","timestamp":1784790268327,"version":"3.55.0"},"reference-count":31,"publisher":"MDPI AG","issue":"15","license":[{"start":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:00:00Z","timestamp":1784764800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Background: Merkel cell carcinoma (MCC) is a rare, aggressive cutaneous neuroendocrine malignancy. Like cutaneous malignant melanomas, a subset of MCCs can clinically present without an identifiable primary tumour, termed Merkel cell carcinoma of unknown primary (UPMCC), with incompletely understood behaviour and prognosis. Our objectives are to evaluate the clinical presentation, management and survival outcomes in UPMCC and compare overall survival with metastatic MCC of known-primary origin. Methods: A retrospective review of 252 consecutive MCC patients (1992\u20132023) identified 20 cases of histologically confirmed nodal or metastatic UPMCC. Demographics, anatomical distribution, treatment and oncological outcomes were analysed. Overall survival was compared with patients presenting with metastatic MCC of known primary. Results: The cohort included 15 males and 5 females (mean age 76 years). Presentation most commonly involved inguinal (n = 7) and axillary (n = 6) nodes, followed by parotid and cervical basins (n = 4). Management was multimodal, including lymphadenectomy, radiotherapy and systemic therapy. Six patients remained disease-free at a mean follow-up of 63.3 months. The mean overall survival was 43.65 months for UPMCC versus 39.29 months for known-primary metastatic MCC. Conclusions: UPMCC most commonly presents as inguinal or axillary nodal disease. Survival outcomes suggest a trend toward improved prognosis compared to known-primary metastatic MCC.<\/jats:p>","DOI":"10.3390\/cancers18152368","type":"journal-article","created":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T06:11:42Z","timestamp":1784787102000},"page":"2368","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A 30-Year Single-Centre Series of Unknown Primary Merkel Cell Carcinoma: Management and Prognosis"],"prefix":"10.3390","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-7149-046X","authenticated-orcid":false,"given":"Aikaterini","family":"Bini","sequence":"first","affiliation":[{"name":"Department of Plastic Surgery, The Christie NHS Foundation Trust, Manchester M20 4BX, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roxana","family":"Totorean","sequence":"additional","affiliation":[{"name":"Department of Plastic Surgery, The Christie NHS Foundation Trust, Manchester M20 4BX, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9689-7235","authenticated-orcid":false,"given":"Hemant","family":"Kumar","sequence":"additional","affiliation":[{"name":"Department of Plastic Surgery, The Christie NHS Foundation Trust, Manchester M20 4BX, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4136-6872","authenticated-orcid":false,"given":"Titus","family":"Grecu","sequence":"additional","affiliation":[{"name":"Department of Plastic Surgery, The Christie NHS Foundation Trust, Manchester M20 4BX, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9627-6914","authenticated-orcid":false,"given":"Patrick","family":"Shenjere","sequence":"additional","affiliation":[{"name":"Department of Pathology, The Christie NHS Foundation Trust, Manchester M20 4BX, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-0565-6201","authenticated-orcid":false,"given":"Deemesh","family":"Oudit","sequence":"additional","affiliation":[{"name":"Department of Plastic Surgery, The Christie NHS Foundation Trust, Manchester M20 4BX, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,7,23]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/s41571-018-0103-2","article-title":"The biology and treatment of Merkel cell carcinoma: Current understanding and research priorities","volume":"15","author":"Harms","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.1245\/s10434-011-2213-2","article-title":"Merkel cell carcinoma of unknown primary origin","volume":"19","author":"Deneve","year":"2012","journal-title":"Ann. Surg. Oncol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1002\/ijc.34020","article-title":"Hypothesised cutaneous sites of origin of stage III melanomas with unknown primary: A multicentre study","volume":"151","author":"Clayton","year":"2022","journal-title":"Int. J. Cancer"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"e55","DOI":"10.1002\/ski2.55","article-title":"Merkel cell carcinoma","volume":"1","author":"Mistry","year":"2021","journal-title":"Skin. Health Dis."},{"key":"ref_5","unstructured":"(2026, July 14). NCCN Guidelines Version 2.2025 for Merkel Cell Carcinoma; Version 2.2025\u201418 April 2025. Available online: https:\/\/merkelcell.org\/news-and-publications\/2025\/nccn-guidelines-version-2-2025-for-merkel-cell-carcinoma\/."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Donizy, P., Wr\u00f3blewska, J.P., Dias-Santagata, D., Woznica, K., Biecek, P., Mochel, M.C., Wu, C.L., Kopczynski, J., Pieniazek, M., and Ry\u015b, J. (2021). Merkel Cell Carcinoma of Unknown Primary: Immunohistochemical and Molecular Analyses Reveal Distinct UV-Signature\/MCPyV-Negative and High Immunogenicity\/MCPyV-Positive Profiles. Cancers, 13.","DOI":"10.3390\/cancers13071621"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Fazio, N., Maisonneuve, P., Spada, F., Gervaso, L., Cella, C.A., Pozzari, M., Zerini, D., Pisa, E., Fumagalli, C., and Barberis, M. (2022). Nodal Merkel Cell Carcinoma with Unknown Primary Site and No Distant Metastasis: A Single-Center Series. Cancers, 14.","DOI":"10.3390\/cancers14194777"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0923-1811(00)00103-1","article-title":"Spontaneous regression of merkel cell carcinoma: A comparative study of TUNEL index and tumor-infiltrating lymphocytes between spontaneous regression and non-regression group","volume":"24","author":"Inoue","year":"2000","journal-title":"J. Dermatol. Sci."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.amjsurg.2013.02.005","article-title":"A better prognosis for Merkel cell carcinoma of unknown primary origin","volume":"206","author":"Chen","year":"2013","journal-title":"Am. J. Surg."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1002\/cam4.4562","article-title":"Merkel cell carcinoma in lymph nodes with and without primary origin","volume":"11","author":"Fennig","year":"2022","journal-title":"Cancer Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1002\/jso.27010","article-title":"Merkel cell carcinoma of unknown primary: Clinical presentation and outcomes","volume":"126","author":"Broida","year":"2022","journal-title":"J. Surg. Oncol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.jaad.2012.07.035","article-title":"Unknown primary Merkel cell carcinoma: 23 new cases and a review","volume":"68","author":"Tarantola","year":"2013","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1002\/lary.23222","article-title":"Merkel cell carcinoma: Identification of prognostic factors unique to tumors located in the head and neck based on analysis of SEER data","volume":"122","author":"Smith","year":"2012","journal-title":"Laryngoscope"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1038\/modpathol.2013.250","article-title":"Merkel cell carcinoma of lymph node with unknown primary has a significantly lower association with Merkel cell polyomavirus than its cutaneous counterpart","volume":"27","author":"Pan","year":"2014","journal-title":"Mod. Pathol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"850797","DOI":"10.1155\/2013\/850797","article-title":"A practical update of surgical management of merkel cell carcinoma of the skin","volume":"2013","author":"Tai","year":"2013","journal-title":"ISRN Surg."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Naseri, S., Steiniche, T., Ladekarl, M., B\u00f8nnelykke-Behrndtz, M.L., H\u00f6lmich, L.R., Langer, S.W., Venzo, A., Tabaksblat, E., Klausen, S., and Skaarup Larsen, M. (2020). Management Recommendations for Merkel Cell Carcinoma-A Danish Perspective. Cancers, 12.","DOI":"10.3390\/cancers12030554"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"e180077","DOI":"10.1001\/jamaoncol.2018.0077","article-title":"Efficacy and Safety of First-line Avelumab Treatment in Patients with Stage IV Metastatic Merkel Cell Carcinoma: A Preplanned Interim Analysis of a Clinical Trial","volume":"4","author":"Russell","year":"2018","journal-title":"JAMA Oncol."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Tai, P., Alqaisi, O., Al-Ghabeesh, S., Sijarina, L., Yu, E., Thachuthara, A.J., Assouline, A., Souied, O., Hagel, K., and Joseph, K. (2025). Immune Checkpoint Inhibitors in Merkel Cell Carcinoma of the Skin: A 2025 Comprehensive Review. Cancers, 17.","DOI":"10.20944\/preprints202507.2063.v1"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.clon.2015.04.007","article-title":"Merkel Cell Carcinoma: Current Management and Controversies","volume":"27","author":"Prewett","year":"2015","journal-title":"Clin. Oncol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"102977","DOI":"10.1016\/j.esmoop.2024.102977","article-title":"Merkel-cell carcinoma: ESMO-EURACAN Clinical Practice Guideline for diagnosis, treatment and follow-up","volume":"9","author":"Lugowska","year":"2024","journal-title":"ESMO Open"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1080\/21691401.2023.2244998","article-title":"Dissecting the tumour immune microenvironment in merkel cell carcinoma based on a machine learning framework","volume":"51","author":"Cheng","year":"2023","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Konstantaraki, M., Berdiaki, A., Neagu, M., Zurac, S., Krasagakis, K., and Nikitovic, D. (2025). Understanding Merkel Cell Carcinoma: Pathogenic Signaling, Extracellular Matrix Dynamics, and Novel Treatment Approaches. Cancers, 17.","DOI":"10.3390\/cancers17071212"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Ouyang, K., Zheng, D.X., and Agak, G.W. (2022). T-Cell Mediated Immunity in Merkel Cell Carcinoma. Cancers, 14.","DOI":"10.3390\/cancers14246058"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1158\/1078-0432.CCR-17-1678","article-title":"Merkel Cell Carcinoma Patients Presenting Without a Primary Lesion Have Elevated Markers of Immunity, Higher Tumor Mutation Burden, and Improved Survival","volume":"24","author":"Vandeven","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Zaggana, E., Konstantinou, M.P., Krasagakis, G.H., de Bree, E., Kalpakis, K., Mavroudis, D., and Krasagakis, K. (2022). Merkel Cell Carcinoma-Update on Diagnosis, Management and Future Perspectives. Cancers, 15.","DOI":"10.3390\/cancers15010103"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jaad.2011.09.009","article-title":"Merkel cell carcinoma: The prognostic implications of an occult primary in stage IIIB (nodal) disease","volume":"67","author":"Foote","year":"2012","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.critrevonc.2014.12.005","article-title":"Neuroendocrine Merkel cell nodal carcinoma of unknown primary site: Management and outcomes of a rare entity","volume":"94","author":"Kotteas","year":"2015","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.jaad.2022.06.015","article-title":"Oncologic outcomes of patients with lymph node-positive Merkel cell carcinoma with unknown primary: A retrospective cohort study","volume":"88","author":"Hui","year":"2023","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.jaad.2025.10.029","article-title":"Differences in Survival Improvement Between Known and Unknown Primary Merkel Cell Carcinoma in the Era of Immune Checkpoint Inhibitors","volume":"94","author":"Luo","year":"2025","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"3151","DOI":"10.1200\/JCO.23.02054","article-title":"Circulating Tumor DNA Assay Detects Merkel Cell Carcinoma Recurrence, Disease Progression, and Minimal Residual Disease: Surveillance and Prognostic Implications","volume":"42","author":"Akaike","year":"2024","journal-title":"J. Clin. Oncol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.jaad.2025.10.032","article-title":"Circulating tumor DNA level is associated with time to clinical recurrence in Merkel cell carcinoma: Implications for patient management","volume":"94","author":"Akaike","year":"2026","journal-title":"J. Am. Acad. Dermatol."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/18\/15\/2368\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T06:16:37Z","timestamp":1784787397000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/18\/15\/2368"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,23]]},"references-count":31,"journal-issue":{"issue":"15","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["cancers18152368"],"URL":"https:\/\/doi.org\/10.3390\/cancers18152368","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,23]]}}}